Sort   by:  
 Page size 
UnknownSARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity.
Not available
S-EPMC8707919 | biostudies-literature
UnknownReconstruction of antibody dynamics and infection histories to evaluate dengue risk.
Not available
S-EPMC6064976 | biostudies-literature
UnknownAntigenic distance between primary and secondary dengue infections correlates with disease risk.
Not available
S-EPMC12336440 | biostudies-literature
UnknownAntigenic evolution of dengue viruses over 20 years.
Not available
S-EPMC8693836 | biostudies-literature
UnknownDengue virus IgG and neutralizing antibody titers measured with standard and mature viruses are protective.
Not available
S-EPMC11697199 | biostudies-literature
UnknownBeneath the surface: Amino acid variation underlying two decades of dengue virus antigenic dynamics in Bangkok, Thailand.
Not available
S-EPMC9098070 | biostudies-literature
UnknownZika virus infection enhances future risk of severe dengue disease.
Not available
S-EPMC8274975 | biostudies-literature
UnknownDengue viruses cluster antigenically but not as discrete serotypes.
Not available
S-EPMC4876809 | biostudies-literature
UnknownComparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.
Not available
S-EPMC10557678 | biostudies-literature
UnknownComparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.
Not available
S-EPMC12362660 | biostudies-literature
Sort   by:  
 Page size